MarketPulse

analyst price target

7 articles
Investing.comInvesting.com··Tim Baker

Moderna Surges on Hantavirus Vaccine Success, Signaling mRNA Platform Diversification

Moderna stock rises after positive Phase 1 hantavirus vaccine data, with analysts raising price targets amid signs of mRNA platform diversification beyond COVID.
MRNAclinical trialpipeline expansion
The Motley FoolThe Motley Fool··Thomas Niel

Green Thumb Stock Looks Cheap: Licensing Deal Shift Could Unlock 100% Upside

Green Thumb stock fell 10% YTD despite analyst targets doubling current prices. A licensing deal shift to $70M fixed annual fee could significantly boost earnings as revenue expands.
RYMearnings growthcannabis stocks
BenzingaBenzinga··Erica Kollmann

Amazon Stock Hits 16-Year Valuation Low: Recession Pricing or Buying Opportunity?

Amazon trades at lowest forward P/E since 2008 despite strong AWS growth, prompting analysts to call stock 'mispriced' with significant upside potential.
AMZNGOOGGOOGLvaluation compressionforward P/E ratio
The Motley FoolThe Motley Fool··David Jagielski, Cpa

Robinhood Stock Plunges 50% YTD—Is a Rebound in the Cards?

$HOOD plunged 50% in 12 months despite analysts targeting 78% upside at current valuations. Street sees opportunity despite competitive and macro headwinds.
HOODprediction marketsvaluation
BenzingaBenzinga··Erica Kollmann

Meta Stock Crashes 25% Into Oversold Territory as Wall Street Sees 55% Rebound Opportunity

Meta stock plunges 25% from highs, hitting oversold RSI levels. Analysts maintain $854 target, suggesting significant recovery potential despite AI capex concerns.
METAtechnical analysismean reversion
The Motley FoolThe Motley Fool··Harsh Chauhan

IonQ Positioned to Lead Quantum Computing Race Despite Valuation Skepticism

IonQ tripled 2025 revenue to $130M with 2026 guidance of $225-245M, targeting quantum market projected to grow from $4B to $72B by 2035.
IONQIONQ.WSvaluationquantum computing
The Motley FoolThe Motley Fool··Dave Kovaleski

Microsoft Stock Rebounds From $410 Lows as Analysts Maintain $600 Bull Case

Microsoft shares fell 24% to $410 from October 2026 highs amid Azure AI slowdown concerns, but analysts see 48% upside with $600 median target.
MSFTAMZNcapital expendituresAI spending